Related Experiment Video
Updated: Jun 20, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
[C-reactive protein and carotid intima-media thickness in atherothrombotic ischemic stroke]
Jose Carlos Arévalo Lorido1, Juana Carretero Gómez
1Servicio de Medicina Interna, Hospital de Zafra, Badajoz, España.
Insights
C-reactive protein (CRP) elevation indicates increased carotid artery intima-media thickness (IMT) in ischemic stroke patients. Higher CRP levels correlate with worse functional outcomes and increased cardiovascular risk, necessitating intensive secondary prevention.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Biomarkers
Context:
- Atherothrombotic ischemic stroke is a leading cause of disability.
- Carotid artery intima-media thickness (IMT) is a marker of atherosclerosis.
- C-reactive protein (CRP) is an inflammatory biomarker.
Purpose:
- To investigate the relationship between CRP levels and carotid artery IMT in patients with atherothrombotic ischemic stroke.
- To determine if CRP levels can predict IMT and functional outcomes.
Summary:
- This study included 135 patients within 48 hours of ischemic stroke.
- CRP levels and carotid ultrasonography were performed.
- Patients were grouped by IMT tertiles, and CRP levels, functional disability, and vascular risk were analyzed.
- A significant elevation of CRP was found across IMT groups (p<0.0008).
Impact:
- CRP is a significant marker for increased IMT in atherothrombotic ischemic stroke.
- A CRP cutoff of 1.5 mg/dL predicts greater IMT, worse functional disability, and higher cardiovascular risk.
- Patients with CRP levels ≥1.5 mg/dL require more intensive secondary prevention strategies.
Background And Objective:
We aimed to investigate the relation between values of C-reactive protein (CRP) and carotid artery intima-media thickness (IMT) in patients with atherothrombotic ischemic stroke.
Patients And Method:
One hundred and thirty five patients within 48h after index ischemic stroke were included. CRP levels were obtained at this time and a carotid ultrasonography was performed. Neurological and functional disability were evaluated, and all patients underwent a cardiovascular risk stratification. Patients were divided in three groups according to the tertiles of they IMT distribution. We adjusted for the possible confounding effect using a multivariate logistic model.
Results:
Forty three in-patients were classified into group 1 (IMT between 0.7 and 1.1 millimetres), 43 into group 2 (IMT between 1.2 and 1.5 millimetres) and 49 into group 3 (IMT higher of 1.6 millimetres). We found a significant elevation of CRP levels at different groups (p<0.0008), with medians by group of 0.3, 0.4 and 1.5mg/dl respectively. Likewise, we found significant differences by group in functional disability (p<0.03) and in vascular risk stratification (p<0.02).
Conclusions:
CRP is a marker of increased IMT in patients with atherothrombotic ischemic stroke. A cutoff point of 1.5mg/dl for CRP provided a greater IMT and a worse outcome in functional disability as cardiovascular risk. Therefore, this group requires a more intensive treatment in secondary prevention.
More Related Videos
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Ischemic Stroke l: Introduction
Atherosclerosis I: Introduction